Tabary X, Moreau N, Dureuil C, Le Goffic F
Centre d'Etudes et de Recherche en Chimie Organique Appliquée, Centre National de la Recherche Scientifique, Thiais, France.
Antimicrob Agents Chemother. 1987 Dec;31(12):1925-8. doi: 10.1128/AAC.31.12.1925.
Two coumarins, inhibitors of the B subunit of DNA gyrase, and six quinolones, inhibitors of the A subunit, were tested against Escherichia coli topoisomerase I-catalyzed DNA relaxation. Coumarins had no effect, whereas quinolones were inhibitors of the enzyme. This inhibition was compared with that of DNA gyrase and calf thymus topoisomerase I. The 50% inhibitory concentrations for E. coli topoisomerase I were about one order of magnitude higher than the corresponding values for E. coli DNA gyrase but were far lower than the known values for calf thymus topoisomerase I. There was a good relationship between inhibition of the two prokaryotic topoisomerases and MICs for E. coli, and the quinolones could be ranked in the same order in the three cases.
测试了两种香豆素(DNA促旋酶B亚基抑制剂)和六种喹诺酮类药物(A亚基抑制剂)对大肠杆菌拓扑异构酶I催化的DNA松弛作用的影响。香豆素没有作用,而喹诺酮类药物是该酶的抑制剂。将这种抑制作用与DNA促旋酶和小牛胸腺拓扑异构酶I的抑制作用进行了比较。大肠杆菌拓扑异构酶I的50%抑制浓度比大肠杆菌DNA促旋酶的相应值高约一个数量级,但远低于小牛胸腺拓扑异构酶I的已知值。两种原核拓扑异构酶的抑制作用与大肠杆菌的最低抑菌浓度(MIC)之间存在良好的关系,在这三种情况下喹诺酮类药物可以按相同顺序排列。